RCM Technologies, Inc. — Form 10-K Summary
Period clarification: Despite the request metadata referencing 2014 Q4, this filing covers fiscal 2015, the 52 weeks ended January 2, 2016, and compares results with fiscal 2014, the 53 weeks ended January 3, 2015. Fiscal 2015 fourth-quarter results are also reported. Dollar amounts below are in millions unless stated otherwise.
Business context
RCM provides engineering, information technology and specialty health care staffing and consulting services through 29 offices in North America. Fiscal 2015 revenue mix was Engineering 43.4%, IT 31.7% and Specialty Health Care 24.9%.
Financial performance and changes
- Revenue: $185.7, down 4.1% from $193.8. The current year was one week shorter. Engineering revenue fell $19.0; IT decreased $0.3; Specialty Health Care rose $11.3.
- Profitability: Gross profit was $51.9 versus $51.7; gross margin improved to 27.9% from 26.7%. Operating income declined to $7.9 from $10.5, and operating margin to 4.2% from 5.5%. Net income was $6.0 versus $6.8; diluted EPS was $0.47 versus $0.54.
- Drivers: Lower service costs and a better revenue mix lifted gross margin, but SG&A increased 6.5% to $42.6, reflecting investment in personnel and infrastructure and higher insurance and equity compensation costs. Other expense was $0.7 versus other income of $0.1, including increased borrowing costs and a $0.1 loss on sale of an IT business unit. The effective tax rate fell to 15.9% from 35.7%, principally due to a tax benefit related to the sale.
- Segments: Engineering revenue fell 19.1% to $80.7 and operating income fell to $3.4 from $6.9, primarily amid reduced Canadian project activity and currency translation; its margin improved to 25.1% from 23.9%. IT revenue was $58.9, essentially flat, and operating income was $3.0 versus $3.2. Specialty Health Care revenue grew 32.4% to $46.1 and operating income rose to $1.5 from $0.4.
- Cash flow: Operating activities provided $12.5, up from $4.2, with collections of aged Canadian receivables a contributor. Investing activities used $3.0; financing activities used $14.2. Cash ended at $1.0, down from $6.4.
- Debt and liquidity: Revolver borrowings were $21.0 versus $20.0; $13.2 remained available under the $35.0 facility, with $0.8 in letters of credit. The facility matures December 11, 2019; the company reported covenant compliance. Total assets were $81.3 and total liabilities $49.1. Current assets were $64.5 and current liabilities $26.9.
- Shareholder returns: The company paid a $1.00-per-share special dividend ($12.5 total) and repurchased 585,966 shares for $2.8 during fiscal 2015. The revolver restricts dividends absent lender consent.
- Fourth quarter: Fiscal 2015 Q4 revenue was $47.4, operating income $2.4, net income $3.0 and diluted EPS $0.24. The comparable fiscal 2014 quarter reported revenue of $49.3, operating income $2.6, net income $1.7 and diluted EPS $0.14; that quarter had 14 weeks.
Outlook, risks and unusual items
- Management gave no quantified revenue or earnings guidance. It cited economic and client-spending uncertainty, competition and pricing pressure, and intends to pursue higher-margin solutions, internal growth and selective acquisitions.
- Management said capital resources should meet normal obligations for at least 12 months. Planned technology investments include up to $1.2 for the first phase of a project-management platform, potentially another $0.6 for expansion, and an estimated $1.0–$2.0 to upgrade or replace the aging financial reporting system, possibly beginning in late fiscal 2016.
- Canadian currency weakness reduced reported fiscal 2015 revenue by an estimated $4.6 versus the prior-year exchange rate. Management does not hedge foreign operations. Canadian and Puerto Rico operations generated about 19.2% of revenue outside the United States.
- Customer concentration remains relevant: the five largest customers generated 33.7% of revenue, although no single customer exceeded 10%. New York Power Authority and Ontario Power Group each represented more than 10% of net accounts receivable. The largest customer relationship in Specialty Health Care also has seasonal school-recess exposure.
- Other principal risks include recruiting and retaining qualified staff, dependence on key personnel, claims involving temporary professionals or subcontractors, nuclear-industry exposure and lack of insurance for nuclear-plant accidents, cyber and data-center disruption, self-insured workers’ compensation and medical claims, and acquisition integration and contingent-payment estimates.
- Asserted legal claims sought approximately $1.9 in damages at year-end; the company had accrued $0.2. A prior claim seeking $6.5 was settled without company contribution. The company also estimated $1.8 of future contingent acquisition consideration, subject to performance and estimation uncertainty.
- Management reported effective disclosure controls and internal control over financial reporting. The independent auditor issued an unqualified opinion on the financial statements; it was not engaged to opine on internal-control effectiveness.
Most important facts for investors to verify
- Whether Engineering revenue and profitability stabilize, particularly in Canada, and how much reported performance reflects currency movements versus underlying demand.
- Whether Specialty Health Care growth converts to sustained operating profit after increased SG&A investment.
- Cash generation, receivable collections and available revolver capacity following dividends, repurchases and the decline in year-end cash.
- Customer and receivable concentration, including collections from major utility customers and seasonal education clients.
- Actual costs and timing for planned systems upgrades, and realized results from the SDS acquisition and other contingent consideration.
- Potential developments in legal claims, tax examinations, insurance reserves and compliance with credit-facility covenants.